11. An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma. (September 2022) Authors: Smith, FL; Neill, JC; Wainwright, V Journal: Drug science, policy and law Issue: Volume 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Are the neurocognitive deficits associated with 3, 4-methylenedioxymethamphetamine caused by statistical deficits in ecstasy research? A systematic review. (July 2018) Authors: Amoroso, Timothy Journal: Drug science, policy and law Issue: Volume 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Buprenorphine for the management of kratom dependency during covid-19: A case report. (July 2021) Authors: Gittins, Rosalind; Cole, Samantha Journal: Drug science, policy and law Issue: Volume 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Can prescribed medical cannabis use reduce the use of other more harmful drugs?. (January 2020) Authors: Gittins, Rosalind; Sessa, Ben Journal: Drug science, policy and law Issue: Volume 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials. (March 2022) Authors: Roscoe, Jeremy; Lozy, Olivia Journal: Drug science, policy and law Issue: Volume 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident. (July 2022) Authors: Johnstad, Petter Grahl Journal: Drug science, policy and law Issue: Volume 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Conceptualising a policy framework for the implementation of medical marijuana in the Caribbean territory of Barbados. (August 2018) Authors: Griffith, Alana DD; Cohall, Damian H Journal: Drug science, policy and law Issue: Volume 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Constructing drug effects: A history of set and setting. (January 2017) Authors: Hartogsohn, Ido Journal: Drug science, policy and law Issue: Volume 3(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Corrigendum for The risk of being culpable for or involved in a road crash after using cannabis: A systematic review and meta-analyses. (April 2022) Journal: Drug science, policy and law Issue: Volume 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. De-mythologizing and re-branding of kava as the new 'world drug' of choice. (September 2019) Authors: Aporosa, S Apo Journal: Drug science, policy and law Issue: Volume 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗